Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis

Biomedical Materials

Volumn 3, Issue 3, 2008, Pages

  Pillai, Rajeev Raghavan ^a   Somayaji, Shankari N ^a   Rabinovich, Monica ^a   Hudson, Michael C ^a   Gonsalves, Kenneth E ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; DRUG DOSAGE; DRUG PRODUCTS; HEALTH; NANOPARTICLES; NANOSTRUCTURES; ULTRAVIOLET SPECTROSCOPY;

BURST RELEASE; DRUG LOADINGS; IN VITRO DRUG RELEASE; IN VITRO RELEASES; INTRACELLULAR BACTERIA; NAFCILLIN; PHOSPHATE BUFFER SALINE; PLGA NANOPARTICLES; POLY(DL-LACTIDE-CO-GLYCOLIDE) (PLGA); S. AUREUS; SECOND PHASE; SLOW RELEASES; STAPHYLOCOCCUS AUREUS; UV-VIS SPECTROSCOPY;

NANOSTRUCTURED MATERIALS;

NAFCILLIN; NANOPARTICLE; POLYGLACTIN; ANTIINFECTIVE AGENT; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; EVAPORATION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOMYELITIS; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET SPECTROSCOPY; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; HUMAN; MICROBIOLOGY; PARTICLE SIZE; ULTRASTRUCTURE;

STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; DRUG CARRIERS; HUMANS; LACTIC ACID; MICE; NAFCILLIN; NANOPARTICLES; OSTEOBLASTS; OSTEOMYELITIS; PARTICLE SIZE; POLYGLYCOLIC ACID; STAPHYLOCOCCUS AUREUS;

EID: 52649149266     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/3/3/034114     Document Type: Article

References (47)

1. Ellington J K, Harris M, Webb B, Smith B, Smith T and Hudson M C 2003 Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis J. Bone Joint Surg. Br. 85 918-21
2. Lucke M, Schmidmaier G, Sadoni S, Widemann B, Schiller R, Stemberger A, Haas N P and Raschke M 2003 A new model of implant-related osteomyelitis in rats J. Biomed. Mater. Res. B Appl. Biomater. 67 593-602
3. Ellington J K, Reilly S S, Ramp W K, Smeltzer M S, Kellam J F and Hudson M C 1999 Mechanisms of Staphylococcus aureus invasion of cultured osteoblasts Microb. Pathog. 26 317-23
4. Alexander E H, Rivera F A, Marriot I, Anguita J, Bost K L and Hudson M C 2003 Staphylococcus aureus induced tumor necrosis factor-related apoptosis-inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts BMC Microbiol. 3 5
5. Rabinovich M, Somayaji S, Raghavan Pillai R, Hudson M C, Ellington K, Bosse M, Horton J and Gonsalves K E 2007 Active polymer nanoparticles: delivery of antibiotics Mater. Res. Soc. Symp. Proc. 1019 FF05-06
6. Soppimath K S, Aminadhavi T M, Kulkarni A R and Rudzinski W E 2001 Biodegradable polymeric nanoparticles as drug delivery devices J. Controlled Release 70 1-20
7. Song C X, Labhasetwar V, Murphy H, Qu X, Humphrey W R, Shebuski J R and Levy R J 1997 Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery J. Controlled Release 43 197-212
8. Frank A, Rath S K, Boey F and Venkatraman S 2004 Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co- glycolide) Biomaterials 25 813-21
9. Fukuzaki H, Yoshida M, Asano M, Kumakura M, Mashimo T, Yuasa H, Imai K and Yamanaka H 1990 In vivo characteristics of low molecular weight copolymers composed of l-lactic acid and various dl-hydroxy acids as biodegradable carriers for drug delivery systems Biomaterials 11 441-5
10. Calhoun J H and Mader J T 1997 Treatment of osteomyelitis with a biodegradable antibiotic implant Clin. Ortho. Rel. Res. 341 206-14
11. Mandal T K, Bostanian L A, Graves R A and Chapman S A 2002 Poly(d,l-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system Pharma. Res. 19 1713-9
12. de Faria T J, Machacado de Campos A and Lemos Senna E 2005 Preparation and characterization of poly(d,l-lactide) (PLA) and poly(d,l-lactide)- poly(ethylene glycol) (PLA-PEG) nanocapsules containing antitumoral agent methotrexate Macromol. Symp. 229 228-33
13. Wang N and Wu X S 1998 Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application J. Biomater. Sci. Polym. Edn. 9 75-87
14. Orloff L A, Domb A J, Teomim D, Fishbein I and Golomb G 1997 Biodegradable implant strategies for inhibition of restenosis Adv. Drug Deliv. Rev. 24 3-9
15. Markou C P, Lutostansky E M, Ku D and Hanson S R 1998 A novel method for efficient drug delivery Ann. Biomed. Eng. 26 502-11
16. Meinel L, Illi O E, Zapf J and Malfanti M 2001 Stabilizing insulin-like growth factor-I in poly(dl-lactide-co-glycolide) microspheres J. Controlled Release 70 193-202
17. Burton K W, Shameem M, Thanoo B C and DeLuca P P 2000 Extended release peptide delivery systems through the use of PLGA microsphere combinations J. Biomater. Sci. Polym. Edn. 11 715-29
18. Qian F, Szymanski A and Gao J 2001 Fabrication and characterization of controlled release poly(d,l-lactide- co-glycolide) millirods J. Biomed. Mater. Res. 55 512-22
19. Lu L, Garcia C A and Mikos A G 1996 In vitro degradation of thin poly(dl-lactic-co-glycolic acid) films J. Biomed. Mater. Res. 46 236-44
20. Leroux J C, Gravel P, Balant L and Volet B 1994 Internalization of poly(d,l-1actic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles J. Biomed. Mater. Res. 28 471-81
21. Lamprecht A, Ubrich N, Hombreiro Perez M, Lehr C M, Hoffman M and Maaincent P 1999 Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification Int. J. Pharm. 184 97-105
22. Astete C E and Sabliov C M 2006 Synthesis and characterization of PLGA nanoparticles J. Biomater. Sci. Poly. Edn. 17 247-89
23. Hans M L and Lowman A M 2002 Biodegradable nanoparticles for drug delivery and targeting Current Opinion Sol. State Mater. Sci. 6 319-27
24. Ravi Kumar M N V, Bakowsky U and Lehr C M 2004 Preparation and Characterization of cationic PLGA nanospheres as DNA carriers Biomaterials 25 1771-7
25. Laurencin C T, Attawia A M, Lu L Q, Borden M D, Lu H H, Gorum W J and Lieberman J R 2001 Poly(lactide-co- glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration Biomaterials 22 1271-7
26. Gonsalves K E, Jin S and Baraton M I 1998 Synthesis and surface characterization of functionalized polylactide copolymer microparticles Biomaterials 19 1501-5
27. Kwon H, Lee J, Choi S, Jang Y and Kim J 2001 Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method Colloids Surf. 182 123-30
28. Razzacki S Z et al 2004 Integrated microsystems for controlled drug delivery Adv. Drug Del. Rev. 56 185-98
29. Panyam J and Labhasetwar V 2003 Biodegradable nanoparticles for drug delivery to cells and tissue Adv. Drug Del. Rev. 55 329-47
30. Tan A K and Fink A L 1992 Identification of the site of covalent attachment of nafcillin, a reversible suicide inhibitor of beta-lactamase Biochem. J. 281 191-6
31. Liu M et al 2005 Characterization and release of triptolide-loaded poly(d,l-lactic acid) nanoparticles Eur. Polym. J. 41 375-82
32. Ramp W K, Lenz L G and Kaysinger K K 1994 Medium pH modulates matrix, mineral, and energy metabolism in cultured chick bones and osteoblast-like cells Bone Miner. 24 59-73
33. Ramp W K et al 1991 A serum substitute promotes osteoblast-like phenotypic expression in cultured cells from chick calvariae Bone Miner. 15 1-17
34. Taboada P, Mosquera V, Ruso J M, Sarmiento F and Jones M N 2000 Interaction between penicillins and human serum albumin: a zeta-potential study Langmuir 16 6795-800
35. Gulyaeva N, Zaslavsky A, Lechner P, Chait A and Zaslavsky B 2000 Relative hydrophobicity of organic compounds measured by partitioning in aqueous two-phase systems J. Chromatogr. B 743 187-94
36. Zweers M L T, Engbers G H M, Grijpma D W and Feijen J 2006 Release of anti-restenosis drugs from poly(ethylene oxide)-poly(dl-lactic-co-glycolic acid) nanoparticles J. Controlled Release 114 317-24
37. Varela L M, Garcia M, Perez-Rodriguez M, Taboada P, Ruso J M and Mosquera V 2001 Multilayer adsorption model for the protein-ligand interaction J. Chem. Phys. 114 7682-7
38. Ruso J M, Taboada P, Varela L M, Attwood D and Mosquera V 2001 Adsorption of an amphiphilic penicillin onto human serum albumin: characterization of the complex Biophys. Chem. 92 141-53
39. Jaiswal J, Gupta S K and Kreuter J 2004 Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process J. Controlled Release 96 169-78
40. Stolnik S, Garnett M C, Davies M C, Illum L, Bousta M, Vert M and Davis S S 1995 The colloidal properties of surfactant free biodegradable nanospheres from poly(beta-malic acid-co-benzyl malate)s and poly(lactic acid-co-glycolide) Colloids. Surf. A 97 235-45
41. Washington C 1990 Drug release from microdisperse systems: a critical review Int. J. Pharm. 58 1-12
42. Zhou Y and Wu X Y 2002 Theoretical analysis of dispersed-drug release from planar matrices with a boundary layer in a finite medium J. Controlled Release 84 1-13
43. Arifin D Y, Lee L Y and Wang L H 2006 Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems Adv. Drug Del. Rev. 58 1274-325
44. Siepmann J and Gopferich A 2001 Mathematical modeling of bioerodible, polymeric drug delivery systems Adv. Drug Del. Rev. 48 229-47
45. Alexis F 2005 Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)] Poly. Int. 54 36-46
46. Hudson M C, Ramp W K, Nicholson N C, Williams A S and Nousiainen M T 1995 Internalization of Staphylococcus aureus by cultured osteoblasts Microb. Pathog. 19 409-19
47. Darouiche R O and Hamill R J 1994 Antibiotic penetration of and bactericidal activity within endothelial cells Antimicrob. Agents Chemother. 38 1059-64